Open versus Laparoscopic Surgery for Advanced Low Rectal Cancer
Koya Hida(Kyoto University Hospital), Masahiko Watanabe(The Japanese Society of Gastroenterological Surgery), Ryosuke Okamura(Kyoto University Hospital), Kenji Kawada(Kyoto University Hospital), Seiichiro Yamamoto(National Cancer Centre Japan), Tomonori Akagi(Oita University), Tomohiro Yamaguchi(Japanese Foundation For Cancer Research), Yoshiharu Sakai(The Japanese Society of Gastroenterological Surgery), Michio Yamamoto(Okayama University), Tatsuto Nishigori(Kyoto University Hospital), Tsuyoshi Konishi(Japanese Foundation For Cancer Research), Satoshi Morita(Kyoto University), Suguru Hasegawa(The University of Tokyo), Meiki Fukuda(Osaka Red Cross Hospital), Takashi Akiyoshi(The Japanese Society of Gastroenterological Surgery)
Cited by 121
Related Papers
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
|New England Journal of Medicine|2010|5.6k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial
|The Lancet Oncology|2019|636
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600